LIGHT CHAIN CARDIAC AMYLOIDOSIS

Clinical trials for LIGHT CHAIN CARDIAC AMYLOIDOSIS explained in plain language.

Never miss a new study

Get alerted when new LIGHT CHAIN CARDIAC AMYLOIDOSIS trials appear

Sign up with your email to follow new studies for LIGHT CHAIN CARDIAC AMYLOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Immune cells from cord blood take aim at rare heart disease

Disease control Not yet recruiting

This study tests a new treatment using specially trained immune cells (CAR-NK cells) from donated umbilical cord blood to fight a rare, serious heart condition called light-chain cardiac amyloidosis. The cells target two proteins (BCMA and CD19) on the harmful cells. The trial in…

Matched conditions: LIGHT CHAIN CARDIAC AMYLOIDOSIS

Phase: PHASE1, PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control

Last updated May 12, 2026 13:42 UTC

LIGHT CHAIN CARDIAC AMYLOIDOSIS

Get alerted when new LIGHT CHAIN CARDIAC AMYLOIDOSIS trials appear

Immune cells from cord blood take aim at rare heart disease